Myriad Genetics Q1 2017 Earnings Call

Myriad Genetics' fiscal first-quarter 2017 earnings presentation delivered November 1, 2016, reporting revenue of $177.5M and adjusted EPS of $0.23. The presentation includes financial results, forward-looking statements, and non-GAAP reconciliation data related to the Assurex acquisition.